MLive published an article Nov. 3 on the approval of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11 from the Centers for Disease Control and Prevention.
The article quotes MHA CEO Brian Peters on the value of the approval when it comes to protecting younger children from severe infection and reducing the overall spread of the disease.
“At a time when children’s hospitals throughout Michigan are strained due to high rates of respiratory illness, this approval will keep children safe and help reduce the burden on our hospitals and allow them to focus on their patients with non-COVID illnesses,” said Peters.